Published in Neuropsychopharmacology on January 27, 2010
Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron (2011) 1.83
Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci (2013) 1.50
Neuromodulation of reward-based learning and decision making in human aging. Ann N Y Acad Sci (2011) 1.34
Reversal learning as a measure of impulsive and compulsive behavior in addictions. Psychopharmacology (Berl) (2011) 1.34
Action controls dopaminergic enhancement of reward representations. Proc Natl Acad Sci U S A (2012) 1.29
Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res (2011) 1.29
Dopamine modulates reward-related vigor. Neuropsychopharmacology (2013) 1.22
The touchscreen operant platform for assessing executive function in rats and mice. Nat Protoc (2013) 1.21
Improving response inhibition systems in frontotemporal dementia with citalopram. Brain (2015) 1.12
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res (2012) 1.02
Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev (2013) 0.95
Modelling cognitive affective biases in major depressive disorder using rodents. Br J Pharmacol (2014) 0.94
Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia. Schizophr Bull (2015) 0.93
Serotonin and dopamine play complementary roles in gambling to recover losses. Neuropsychopharmacology (2010) 0.93
Mood as Representation of Momentum. Trends Cogn Sci (2015) 0.91
Assessing anhedonia in depression: Potentials and pitfalls. Neurosci Biobehav Rev (2016) 0.91
The neural basis of reversal learning: An updated perspective. Neuroscience (2016) 0.91
Playing it safe but losing anyway--serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion. Eur Neuropsychopharmacol (2012) 0.89
Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants. Front Integr Neurosci (2013) 0.88
Role of Central Serotonin in Anticipation of Rewarding and Punishing Outcomes: Effects of Selective Amygdala or Orbitofrontal 5-HT Depletion. Cereb Cortex (2014) 0.88
Consideration of species differences in developing novel molecules as cognition enhancers. Neurosci Biobehav Rev (2012) 0.87
Differential effects of 5-HT(2A) and 5-HT(2C) receptor blockade on strategy-switching. Behav Brain Res (2011) 0.87
5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. Int J Neuropsychopharmacol (2011) 0.86
Reduced sensitivity to both positive and negative reinforcement in mice over-expressing the 5-hydroxytryptamine transporter. Eur J Neurosci (2014) 0.86
CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning. Schizophr Bull (2011) 0.86
Environmental rearing effects on impulsivity and reward sensitivity. Behav Neurosci (2013) 0.85
The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning. J Psychopharmacol (2012) 0.84
Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. Front Neurosci (2013) 0.83
Age of exposure-dependent effects of amphetamine on behavioral flexibility. Behav Brain Res (2013) 0.83
Isolation rearing effects on probabilistic learning and cognitive flexibility in rats. Cogn Affect Behav Neurosci (2014) 0.82
The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia. Psychopharmacology (Berl) (2015) 0.82
The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study. Psychopharmacology (Berl) (2015) 0.81
Activity patterns of serotonin neurons underlying cognitive flexibility. Elife (2017) 0.80
GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders. Neuropsychopharmacology (2015) 0.80
Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation. Neuropsychopharmacology (2013) 0.80
Cross-species studies of cognition relevant to drug discovery: A translational approach. Br J Pharmacol (2017) 0.80
Pedunculopontine tegmental nucleus lesions impair probabilistic reversal learning by reducing sensitivity to positive reward feedback. Neurobiol Learn Mem (2016) 0.79
Noradrenergic modulation of risk/reward decision making. Psychopharmacology (Berl) (2015) 0.79
Ongoing behavioral state information signaled in the lateral habenula guides choice flexibility in freely moving rats. Front Behav Neurosci (2015) 0.79
Social brains on drugs: tools for neuromodulation in social neuroscience. Soc Cogn Affect Neurosci (2013) 0.78
Dissociable effects of 5-HT2C receptor antagonism and genetic inactivation on perseverance and learned non-reward in an egocentric spatial reversal task. PLoS One (2013) 0.78
Cognitive Judgment Bias Interacts with Risk Based Decision Making and Sensitivity to Dopaminergic Challenge in Male Rats. Front Behav Neurosci (2016) 0.77
Serotonergic modulation of 'waiting impulsivity' is mediated by the impulsivity phenotype in humans. Transl Psychiatry (2016) 0.77
Effects of acute treatment with a tryptophan-rich protein hydrolysate on plasma amino acids, mood and emotional functioning in older women. Psychopharmacology (Berl) (2014) 0.76
Using mice to model Obsessive Compulsive Disorder: From genes to circuits. Neuroscience (2015) 0.76
Acute serotonin depletion releases motivated inhibition of response vigour. Psychopharmacology (Berl) (2014) 0.76
A specific role for serotonin in overcoming effort cost. Elife (2016) 0.76
Toward a theoretical role for tonic norepinephrine in the orbitofrontal cortex in facilitating flexible learning. Neuroscience (2016) 0.76
A biopsychosocial model of violence when sleepwalking: review and reconceptualisation. BJPsych Open (2017) 0.75
Adolescent GBR12909 exposure induces oxidative stress, disrupts parvalbumin-positive interneurons, and leads to hyperactivity and impulsivity in adult mice. Neuroscience (2016) 0.75
Cognitive flexibility impairment and reduced frontal cortex BDNF expression in the ouabain model of mania. Neuroscience (2016) 0.75
Preservation of Essential Odor-Guided Behaviors and Odor-Based Reversal Learning after Targeting Adult Brain Serotonin Synthesis. eNeuro (2016) 0.75
Tryptophan depletion affects compulsive behaviour in rats: strain dependent effects and associated neuromechanisms. Psychopharmacology (Berl) (2017) 0.75
An Evolutionary Hypothesis of Binary Opposition in Functional Incompatibility about Habenular Asymmetry in Vertebrates. Front Neurosci (2017) 0.75
Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task. Psychopharmacology (Berl) (2016) 0.75
Budget Constraints Affect Male Rats' Choices between Differently Priced Commodities. PLoS One (2015) 0.75
Perseveration in a spatial-discrimination serial reversal learning task is differentially affected by MAO-A and MAO-B inhibition and associated with reduced anxiety and peripheral serotonin levels. Psychopharmacology (Berl) (2017) 0.75
A neural substrate of prediction and reward. Science (1997) 31.30
By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science (2004) 7.92
The mesolimbic dopamine reward circuit in depression. Biol Psychiatry (2006) 7.62
Opponent interactions between serotonin and dopamine. Neural Netw (2002) 4.12
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience (1991) 4.05
Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex (2000) 3.75
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex (2001) 3.67
Attentional biases for negative interpersonal stimuli in clinical depression. J Abnorm Psychol (2004) 3.65
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex (2000) 3.44
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia (2000) 2.26
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci (1996) 2.22
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse (1987) 2.20
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Serotonin in affective control. Annu Rev Neurosci (2009) 2.10
Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav (1996) 2.03
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
5-HT and mechanisms of defence. J Psychopharmacol (1991) 1.99
Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99
Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res (2007) 1.98
Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med (1996) 1.84
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) (1997) 1.83
Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation. Biol Psychiatry (2003) 1.76
Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) (2003) 1.73
Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol Med (1996) 1.71
Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med (2003) 1.59
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry (2004) 1.59
Reward fails to alter response bias in depression. J Abnorm Psychol (1994) 1.57
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) (2002) 1.56
Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology (2007) 1.52
Pupillary and reaction time measures of sustained processing of negative information in depression. Biol Psychiatry (2001) 1.51
Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment. J Neurol Neurosurg Psychiatry (1997) 1.50
Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology (2005) 1.49
Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) (2002) 1.46
A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol (2007) 1.43
The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology (2005) 1.38
Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage (2008) 1.37
Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr (2002) 1.36
5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol (1989) 1.35
5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem (1975) 1.29
Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res (1992) 1.26
Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol (1995) 1.26
GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci (1999) 1.24
Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology (2006) 1.18
Error rate and outcome predictability affect neural activation in prefrontal cortex and anterior cingulate during decision-making. Neuroimage (2002) 1.17
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology (Berl) (1997) 1.16
Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol (1991) 1.15
Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) (2005) 1.14
Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection. Neuropsychologia (1999) 1.12
Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology (2006) 1.12
Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol (1992) 1.12
Probabilistic reversal learning is impaired in Parkinson's disease. Neuroscience (2009) 1.06
The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Neuropharmacology (2003) 1.06
Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport (2007) 1.05
R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology (2002) 1.05
Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets (2006) 1.01
Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch Pharmacol (1995) 1.01
Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm (1978) 1.00
Periodic maternal separation of neonatal rats produces region- and gender-specific effects on biogenic amine content in postmortem adult brain. Synapse (2001) 1.00
The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem (2005) 0.98
Performance feedback deficit in geriatric depression. Biol Psychiatry (2001) 0.98
Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry (1976) 0.97
Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol (2004) 0.94
Hot and cold cognition in unmedicated depressed subjects with bipolar disorder. Bipolar Disord (2009) 0.93
R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behav Pharmacol (2003) 0.93
Measurement of reinforcement in depression: a pilot study. J Behav Ther Exp Psychiatry (1985) 0.93
De- and regeneration of the bulbospinal serotonin neurons in the rat following 5,6-or 5,7-dihydroxytryptamine treatment. Cell Tissue Res (1974) 0.92
Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology (Berl) (1992) 0.91
Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology (2000) 0.90
Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci (2009) 0.89
Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol (1994) 0.89
Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol (1994) 0.89
Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Brain Res Bull (1998) 0.88
Depression and 5HT. Int Clin Psychopharmacol (1991) 0.85
Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Synapse (1999) 0.83
Effects of acute citalopram on the expression of conditioned freezing in naive versus chronic citalopram-treated rats. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.82
Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.81
Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J Neurochem (1999) 0.80
Differential effects of forebrain 5-hydroxytryptamine depletions on Pavlovian aversive conditioning to discrete and contextual stimuli in the rat. Eur J Neurosci (1995) 0.80
Modulation of the brain aversive system by GABAergic and serotonergic mechanisms. Behav Brain Res (1986) 0.78
Neuropsychology--dementia and affective disorders. Br Med Bull (1996) 0.77
Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study. Psychiatry Clin Neurosci (2008) 0.76
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 3.96
Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci (2002) 3.50
Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci (2004) 3.48
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85
Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol (2013) 2.85
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81
IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci (2006) 2.71
Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci (2003) 2.70
Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res (2008) 2.61
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52
Serotonin modulates behavioral reactions to unfairness. Science (2008) 2.49
Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci (2002) 2.49
Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A (2010) 2.47
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24
Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci (2003) 2.22
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology (2009) 2.21
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav (2007) 2.19
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13
A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11
Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09
The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) (2008) 2.07
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Decision-making in the adolescent brain. Nat Neurosci (2012) 2.05
Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology (2005) 1.89
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev (2013) 1.88
Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci (2008) 1.88
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol (2010) 1.85
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82
Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81
Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology (2007) 1.81
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.80
Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex (2005) 1.80
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79
Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry (2006) 1.78
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain (2002) 1.75
Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) (2003) 1.73
Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J Neurosci (2004) 1.71
Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron (2011) 1.71
Personality, addiction, dopamine: insights from Parkinson's disease. Neuron (2009) 1.71
Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 1.71
Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology (2006) 1.66
Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in rats. Behav Neurosci (2002) 1.65
Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci (2004) 1.64
Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning. Neuron (2004) 1.64
High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry (2009) 1.63
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci (2009) 1.61
White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry (2008) 1.60
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) (2004) 1.58
Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.56
Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry (2011) 1.56
Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res (2007) 1.55